Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference and the Piper Sandler 33rd Annual Healthcare ConferenceGlobeNewsWire • 11/15/21
Lexicon's Sotagliflozin Demonstrates Benefits in Heart Failure and Blood Glucose Control Across the Full Range of Kidney Function in New Analysis of Clinical DataGlobeNewsWire • 11/14/21
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21
Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical UpdateGlobeNewsWire • 11/03/21
Lexicon Pharmaceuticals to Host Third Quarter 2021 Financial Results Conference Call and Webcast on November 3, 2021GlobeNewsWire • 10/28/21
Lexicon Welcomes New ESC Heart Failure Treatment Guidelines Establishing SGLT Inhibitors as Standard of CareGlobeNewsWire • 08/30/21
Lexicon's Sotagliflozin Demonstrates Additional Compelling Benefits in Reducing Cardiovascular Endpoints: Results from Soloist and Scored TrialsGlobeNewsWire • 08/23/21
Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical OfficerGlobeNewsWire • 07/30/21
Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical UpdateGlobeNewsWire • 07/30/21
Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on July 30, 2021GlobeNewsWire • 07/28/21
Will Lexicon Pharmaceuticals (LXRX) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/22/21
Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific SessionsGlobeNewsWire • 06/25/21
Lexicon Pharmaceuticals to Participate in the 2021 Jefferies Virtual Healthcare ConferenceGlobeNewsWire • 05/26/21
Lexicon Pharmaceuticals Announces Two Presentations at the American College of Cardiology's 70th Annual Scientific SessionGlobeNewsWire • 05/13/21
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/07/21
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/07/21
Lexicon Pharmaceuticals to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 6, 2021GlobeNewsWire • 04/29/21
Lexicon Pharmaceuticals (LXRX) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/19/21